LATEST HEALTH NEWS

A double-blind, placebo-controlled randomized clinical trial finds the right dosage at which a drug 'safely' treats nonalcoholic fatty liver disease.

from Featured Health News from Medical News Today https://ift.tt/2Zlt34r